Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities
- Author
- Sara A. Hurvitz MD FACP, La-Urshalar B. Brock FNP-BC CNM, Jordan Hill PharmD BCOP
- Published
- Thu 29 May 2025
- Episode Link
- https://oncologypodcast.simplecast.com/episodes/role-of-the-multidisciplinary-team-in-achieving-comprehensive-and-individualized-care-of-patients-with-hr-positive-her2-negative-metastatic-breast-cancer-and-preexisting-comorbidities-1e9ZzWZO
In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities, including:
- Key Comorbidities in Patients with HR+/HER2- MBC
- Impact of Polypharmacy
- Role of APPs in Comprehensive Care
- Role of CDK4/6 Inhibitors and Other Treatments for HR+/HER2- MBC
- Utility of RWE data
- Communicating Treatment Options With Patients and Caregivers
- Understanding Patient Goals and Coordinating With the Multidisciplinary Team to Individualize Treatment and Maximize Quality of Life
Link to full program:
https://bit.ly/4jCQe38
